Rivaroxaban Unknown Status Phase N/A Trials for Blood Loss / Osteoarthritis, Hip Supportive Care

IndicationsStatusPurposePhase
Unknown StatusSupportive CareNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02085824Comparison of Blood Loss Following Total Hip Arthroplasty With the Use of Three Thromboprophylactic Regimes: Dabigatran, Enoxaparin and Rivaroxaban.